"Gemcitabine v\u00A0monoterapii m\u016F\u017Ee b\u00FDt pou\u017Eit u star\u0161\u00EDch pacient\u016F nebo u t\u011Bch se stupn\u011Bm v\u00FDkonnosti 2.\nKarcinom vaje\u010Dn\u00EDk\u016F:\nLok\u00E1ln\u011B pokro\u010Dil\u00FD nebo metastazuj\u00EDc\u00ED epiteli\u00E1ln\u00ED karcinom vaje\u010Dn\u00EDku, v\u00A0kombinaci s\u00A0karboplatinou u pacient\u016F s\u00A0relapsem n\u00E1sleduj\u00EDc\u00EDm po obdob\u00ED bez n\u00E1vratu nemoci v\u00A0trv\u00E1n\u00ED minim\u00E1ln\u011B 6 m\u011Bs\u00EDc\u016F po prvn\u00ED l\u00E9\u010Db\u011B platinou."@cs . . . "1789"^^ . . "1457"^^ . "1"^^ . . . . . .